Table 2 Unadjusted and multivariate adjusted model for association of duodenal invasion with adverse features of pancreatic cancer
From: The prognostic significance of duodenal wall invasion in pancreatic adenocarcinoma
Adverse features of pancreatic cancer | Duodenal invasion, OR (P-value) | |
|---|---|---|
Univariate model | Multivariate modela | |
Age | 1.97 (P = 0.14) | 3.53 (P = 0.07) |
Gender | 1.49 (P = 0.33) | 1.81 (P = 0.34) |
Race | 0.70 (P = 0.61) | 1.09 (P = 0.88) |
Lymphovascular invasion | 2.71 (P = 0.03)* | 0.83 (P = 0.84) |
Lymph node involvement | 3.89 (P = 0.004)* | 9.17 (P = 0.02)* |
Perineural involvement | 2.82 (P = 0.07) | 1.04 (P = 0.96) |
CBD involvement | 1.38 (P = 0.54) | 0.34 (P = 0.16) |
IPMN-associated adenocarcinoma | 0.68 (P = 0.50) | 0.18 (P = 0.06) |
T stage | ||
T2 vs T1 | 1.96 (P = 0.21) | 0.29 (P = 0.15) |
T3 vs T1 | 2.50 (P = 0.14) | 0.98 (P = 0.98) |
Grade | ||
G2 vs G1 | 4.65 (P = 0.18) | 2.09 (P = 0.62) |
G3 vs G1 | 7.11 (P = 0.10) | 4.61 (P = 0.32) |
Margin status | 0.69 (P = 0.41) | 0.86 (P = 0.81) |
Recurrence | 0.98 (P = 0.96) | 1.30 (P = 0.66) |
Mortality | 0.43 (P = 0.054) | 0.13 (P = 0.03)* |